Chih Min Kam

1.2k citations
20 papers · 1.1k indexed · h-index 15

Chih Min Kam

20 papers receiving 1.0k citations

Peers

Chih Min Kam
Comparison fields: 5 of 90
  • Immunology 364
  • Hematology 145
  • Cancer Research 151
  • Molecular Biology 589
  • Oncology 207
Replace Chih-Min Kam with:
Chih-Min Kam United States
J.P. Priestle Switzerland
Dyfed L. Evans United Kingdom
Alain Balland United States
Dominik Fuchs Germany
Kylie A. Hotchkiss United States
Albert Boosman United States
J. G. Holland United States
Erhard Kopetzki Germany
Pierre Beauparlant Canada
Chih Min Kam relative to Chih-Min Kam United States Chih-Min Kam's profile →
Citations per field
00.5×1.5×
Chih-Min Kam · 1×
Citations per year

Countries citing papers authored by Chih Min Kam

Since Specialization
Citations

This map shows the geographic impact of Chih Min Kam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chih Min Kam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chih Min Kam more than expected).

Fields of papers citing papers by Chih Min Kam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chih Min Kam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chih Min Kam. The network helps show where Chih Min Kam may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Chih Min Kam, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Chih Min Kam Line = papers co-authored together Chih Min Kam links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 199814
2 19968
3 19959
4 19933
5 199320
6 199358
7 1992392
8 199232
9 199228
10 199252
11
Synthetic substrates and inhibitors for serine proteases from lymphocytes, mast cells, semen, and blood.
19921
12 199124
13 1991217
14 199030
15 19906
16 199018
17 199019
18 198864
19 198750
20 198716

About Chih Min Kam

Chih Min Kam is a scholar working on Cancer Research, Hematology and Oncology, having authored 20 papers that have together received 1.1k indexed citations. Recurring topics across this work include Synthesis and Biological Activity (7 papers), Peptidase Inhibition and Analysis (6 papers), Chemical Synthesis and Analysis (4 papers), Protease and Inhibitor Mechanisms (4 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers), Synthesis and biological activity (2 papers), Biological Stains and Phytochemicals (2 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). The work is most often cited by research in Immunology (364 citations), Hematology (145 citations) and Cancer Research (151 citations). Chih Min Kam has collaborated with scholars based in United States, Australia and Canada. Frequent co-authors include James C. Powers, Harry B. Greenberg, Ruedi Aebersold, L Shi, Shinjiro Odake, Martin Poe, Lakshmi Narasimhan, Olivier Krähenbühl, J Tschopp and James C. Powers. Their work appears in journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and The Journal of Experimental Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026